Don't you think the MOT has been too quick to delve and talk publicly about digitising the road tax disc?.That when the process has not been tested on pilot run basis,and to evaluate all the shortcomings and ensuing problems arising from the ground.Creating unnecessary adverse market response to company that was awarded the concession to manage the road tax renewals(physical). Source - https://www.freemalaysiatoday.com/category/nation/2023/02/14/no-decision-yet-on-digital-driving-licences-says-loke/

1.The Minister of Transport should be more careful when making public statement on RTD's new policy measure when they are not ready to roll-out yet.They have not conducted and tested the digital system on the trial basis to measure whether the digital system is up to the mark,robust to cater to heavy traffic flows, and examine whatever adverse implications arising.That has to be done yet.In addition any changes from physical road tax disc to digital format requires the amendment to the Section 20,Road Transport Act to be made. Only with the amendment gazetted such trail basis can be extended to all private vehicle ownership .Otherwise it goes against the existing RTD act.
2.Seemed the MOT likes to hog the limelight in the press and received all the publicity without waiting until the system is really properly tested, and then ready to be rolled-out to avoid unnecessary glitches and inconvenience to the public and private vehicle owners.
3.Seemed like such impromptu announcement just days before the Parliament is convened this week seemed to be improperly timed.
4.Read the recent press statement by the erstwhile IGP Musa Hassan that cautioned the MOT on the roll-out of the digital road tax system when inter-agency & transboundary co-ordination has not been discussed and firmed up yet.

From The Edge,Malaysia - Axiata unit Boost and RHB ink deal to jointly bid for digital banking licence

/
June 02, 2021 13:21 pm +08
KUALA LUMPUR (June 2): Axiata Group Bhd's subsidiary Boost Holdings Sdn Bhd and RHB Banking Group have signed a heads of agreement to form a consortium to apply for a digital banking licence from Bank Negara Malaysia (BNM).

In a filing with Bursa Malaysia, Axiata said Boost Holdings would own a majority stake of 60% in the digital bank, while RHB would hold the remaining 40%.

"Celcom Axiata Bhd has signed up as a major commercial partner on joint go-to-market activities with the digital bank for products and services which will benefit customers of both parties," it said.

More to come

From The Edge,Malaysia - Axiata unit Boost and RHB ink deal to jointly bid for digital banking licence

/
June 02, 2021 13:21 pm +08
KUALA LUMPUR (June 2): Axiata Group Bhd's subsidiary Boost Holdings Sdn Bhd and RHB Banking Group have signed a heads of agreement to form a consortium to apply for a digital banking licence from Bank Negara Malaysia (BNM).

In a filing with Bursa Malaysia, Axiata said Boost Holdings would own a majority stake of 60% in the digital bank, while RHB would hold the remaining 40%.

"Celcom Axiata Bhd has signed up as a major commercial partner on joint go-to-market activities with the digital bank for products and services which will benefit customers of both parties," it said.

More to come

OTHERS 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; A


OTHERS 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; AND 2. SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND ("RDIF") AND DMSB, FOR THE DISTRIBUTION OF THE VACCINE IN MALAYSIA.
DUOPHARMA BIOTECH BERHAD

Type Announcement
Subject OTHERS
Description 1. SUPPLY AGREEMENT BETWEEN THE GOVERNMENT OF MALAYSIA ("GOVERNMENT") AND DUOPHARMA (M) SENDIRIAN BERHAD ("DMSB"), A WHOLLY OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD, FOR THE SUPPLY OF THE SPUTNIK V VACCINE ("VACCINE") TO THE GOVERNMENT; AND
2. SUPPLY AGREEMENT BETWEEN A SUBSIDIARY OF THE RUSSIAN DIRECT INVESTMENT FUND ("RDIF") AND DMSB, FOR THE DISTRIBUTION OF THE VACCINE IN MALAYSIA.
We refer to the announcements made on 26 January 2021, 25 February 2021, 11
March 2021, 1 April 2021, 9 April 2021 and 30 April 2021 in relation to the
RDIF Term Sheet and the Government Term Sheet (“Announcements”). For
consistency purposes, the abbreviations used in this announcement are the same
as those previously defined in the Announcements unless otherwise defined
herein.

The Board of Directors (the “Board”) of Duopharma Biotech Berhad
(“Duopharma Biotech” or the “Company”) wishes to announce the
following:

1. in furtherance of the RDIF Term Sheet, RDIF had nominated and authorised a
subsidiary of RDIF (the “Seller”), to enter into the supply agreement with
DMSB to perform the obligations for the supply of the Vaccine to DMSB as
envisaged under the RDIF Term Sheet;

2. pursuant to the Government Term Sheet, DMSB had on 31 May 2021 received from
the Government for DMSB’s execution a supply agreement dated 25 May 2021
that had been executed by the Government for the supply by DMSB to the
Government of the finished form of the Vaccine upon the terms and conditions
therein contained (the “Government Supply Agreement”), and that DMSB has
executed the Government Supply Agreement; and

3. DMSB has also executed a supply agreement dated 12 May 2021 with the Seller
for the supply to DMSB of the finished form of the Vaccine in the Territory
upon the terms and conditions therein contained.

Please refer to the attachment for details of the announcement.

This announcement is dated 1 June 2021.

OTHERS DUOPHARMA BIOTECH SIGNS WITH THE GOVERNMENT OF MALAYSIA TO SUPPLY RUSSIA'S COVID-19 VACCINE TO MALAYSIA


OTHERS DUOPHARMA BIOTECH SIGNS WITH THE GOVERNMENT OF MALAYSIA TO SUPPLY RUSSIA'S COVID-19 VACCINE TO MALAYSIA
DUOPHARMA BIOTECH BERHAD

Type Announcement
Subject OTHERS
Description DUOPHARMA BIOTECH SIGNS WITH THE GOVERNMENT OF MALAYSIA TO SUPPLY RUSSIA'S COVID-19 VACCINE TO MALAYSIA
We attach herewith a copy of press release dated 1 June 2021.

Please refer attachment below.

This announcement is dated 1 June 2021.

Please refer attachment below.

Attachments

Signing of Definitive Agreement with MOH on Sputnik V (PA) - 1 June 2021.pdf
(https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=115267&name=EA_GA_ATTACHMENTS)

632.5 kB

Axiata, RHB Bank to jointly bid for digital bank licence — sources
SINGAPORE (May 31): Malaysian telco Axiata Group Bhd has teamed up with RHB Bank Bhd to apply for a digital bank licence, two sources familiar with the matter told Reuters on Monday.

The sources declined to be identified as they were not authorised to speak to the media.

Malaysia's central bank has called for digital bank applications by June 30 and said it may issue up to five licences for online-only banks.

Across Asia, regulators are opening up banking for digital players, encouraged by a boom in mobile connectivity and the prospect of tech firms offering low-cost financial services. The Covid-19 pandemic has increased the need for digital transactions.

Axiata declined to comment on the digital bank application with RHB but said in an email it would hold a news conference with the bank on Wednesday "on significant partnerships that will expand collaborations between both parties."

RHB had no immediate comment.

Axiata, RHB Bank to jointly bid for digital bank licence — sources
SINGAPORE (May 31): Malaysian telco Axiata Group Bhd has teamed up with RHB Bank Bhd to apply for a digital bank licence, two sources familiar with the matter told Reuters on Monday.

The sources declined to be identified as they were not authorised to speak to the media.

Malaysia's central bank has called for digital bank applications by June 30 and said it may issue up to five licences for online-only banks.

Across Asia, regulators are opening up banking for digital players, encouraged by a boom in mobile connectivity and the prospect of tech firms offering low-cost financial services. The Covid-19 pandemic has increased the need for digital transactions.

Axiata declined to comment on the digital bank application with RHB but said in an email it would hold a news conference with the bank on Wednesday "on significant partnerships that will expand collaborations between both parties."

RHB had no immediate comment.

@The Market very simple if the Covid-19 test instrument is so practicable and portable it will have catch the close attention of MOH and used by all countries. Last year there were many similar products coming out from South Korea on such test kits for virus and pathogens that caused Covid-19 but after the initial hoopla everything quiet and dies down. Even with the drop in today price to RM 1.43 the stock is still overpriced. What basic fundamentals to support such a rich valuation?. Just peruse through the latest quarterly result that was out last weekJust to share.

What a very poor performance for the last quarter which was out this evening. Going to shatter a thousand dreams and break many rice bowls of the investors hoping for sudden great and instant fortune. Just tell me frankly a company wth paid up capital of aboutt RM 204 million can only achieve stagnant revenue flows at about RM 4.564 million and PBT and PAT of only 49,,000. EPS a miserable lowly figure of 0.12 cents. Too many gullible investors of this counter akin to blind following the blind. At the present price is very very very much overpriced and overvalued. At his price me can choose so many other worthy counters from Bursa and can allow me to sleep soundly. To know more read - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=7218

Correction: No plausible,send changed to no plausible reasons. Be smart and don't be foolish.

Good and great price uptrend. Up 0.22 cents today. Rewards to investors holding the value stock through up and down cycles. Cheers.

@Thien0418 do peruse through the latest QR out today. What can you clearly determine and conclude? Seemed like most of the investors in such mediocre performing counter is hibernating,foolish, and caught in the land of thousand elusive dreams of great sudden riches and wealth.Earlier on have been commenting no plausible,send , and logical reasons for the price to skyrocket about two months ago. Even at the present closing price the stock price is very much overvalued and overpriced. Don't be the blind following the blind.Be your own man to decide what to buy or sell. Read through the appended document - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=8338

Really finds it preposterous - MOU that was just signed with the Sabah gvt to procure Sinopharma vaccine from China can garner market's interest on the stock.
A2.That when the company is doing and manufacturing bamboo floor tilings? And for first QR 2021 making hefty losses of RM 22.541 millions. Paid up capital 247million and NTA just 0.106 cents. Weak financials fundamental.
A3.Also when the Federal Gvt has just announced that the country will be receiving more than 16 millions dosses of vaccines by July 2021 and can translate into 150,000 jabs for citizens per day.
A4.Why then the needs for the Sabah get to expend such money to procure the vaccines when billions at Federal get level had been allocated to procure the vaccines to cover all the citizens of 33.3 millions population.
A5.Any good performance company will manage the company well so that performance can be enhanced. Not by going on such route where the forward earnings not visible and sustainable.

Just to share. No prejudice meant but based on available corporate information.

Public Bank beat Maybank this QR. Hope it can sustain and maintain the stellar results. Do keep scoring well.Expects the stock price to trend further upwards as shown from the technical charts perused.

Ex-date 9 JUne2021 for final dividend 7.65 cents.Read - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=1066

Good QR performance as appended and shared above.

https://www.theedgemarkets.com/article/rhb-bank-1q-net-profit-grows-14-yoy-boosted-higher-net-fundbased-and-nonfundbased-incomes

Quick take: Southern Steel rises 10% on turnaround

KUALA LUMPUR: The market reacted positively to the latest financial results from Southern Steel Bhd and its shares were up over 10% in early trade.

The steel products manufacturer advanced 10.05%, or 9.5 sen to RM1.04 with 1.9 million shares done. It has appreciated some 20.4% so far this year.

In the third quarter ended March 31, Southern Steel posted a net profit of RM40.83mil against a net loss of RM37.58mil in the same quarter last year.

Its revenue rose 4.87% to RRM493.27mil in the quarter ended March 31 from RM470.36mil previously.

In the first nine months to March 31, it posted a net profit of RM23.45mil versus a net loss of RM418.12mil.

However, its revenue for the period was 19.3% lower at RM1.38bil from RM1.71bil previously.

Southern Steel said although there was an improvement in the group’s performance, market conditions remained uncertain due to the Covid-19 pandemic.

“The group will continue to be responsive to market changes and the board expects to remain profitable in the final quarter of this financial year,” it said.

Read - https://www.thestar.com.my/business/business-news/2021/05/27/kpower-distances-itself-from-serba-dinamik

Last closing price at RM 3.21 is simply illogical and has overshoot its future earnings or underlying fundamentals. Negative EPS,negative ROE,no dividends for several quarters. Like Sedania present price movement which is simply irrational.Hope the regulators will act strongly on such irregular price manipulation as expected. The regulators have to play their mandated duties and obligations well.The investors clearly expect them to enforce the securities market's laws with no fear or favour. Clearly, a pumped and dumped stock counter that will caught many gullible investors badly.

Have written officially to get the notice of the equity market regulator that this "pump and dump" counter has seen its prices being pumped up for no logical and sound reasons. Last year revenues only about RM 8mil but making huge losses of about RM 12 millions more than the revenues accrued. Paid up capital about RM 363million? Forward earnings also not visible. What fundamentals to support the last closing price at RM 1.20? Have perused through the financials,fundamentals and can obtain no evidential facts to support such price. This is turning the market upside down.

Serba Dinamik's external auditors flag statutory audit matters, to set up independent review. Read - https://www.theedgemarkets.com/article/serba-dinamiks-external-auditors-flags-statutory-audit-matters-set-independent-review

Looking at the quarter result just out opines at even the present price the stock has been overvalued. Read - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=0123

Really find those countless remarks made against @joyvest were most uncouth,uncalled, and unlike any decent public investors.
A2. Why can't we respect other person differing,divergent, or different views,points, opinions from others? Really disgust me?
A3. This channel is an open forum for public investors to make logical, and factual comments and not for attacking another relentlessly day after day.
A4. That is not a mark of civil and progressive investing community.
A5. Respect begets respect.

A company with paid capital of about RM 1.65 billion but last quarter profit only come to about RM2.162 million. What a big letdown to many investors out there in the market dreaming of sudden BIG windfalls. After last quarter result which was out today best to sell and make some profit. View - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=4456

Wonder why so many public investors were so fixated and attracted to such poor performing stock. The latest result only show profit at RM 490k. What a lowly performance for last quarter.No logical reason for the share to fetch such rich valuation at RM 2.70. Peruse through the result out today - https://www.malaysiastock.biz/Stock-Chart.aspx?securitycode=7208&mode=1D

At times me wonder why the public investors were so fixated about this share chasing it to reach new high.Just perused carefully through the latest quarterly report (QR) and the company just made RM 11,000 profit.. What a letdown to all those people out there dreaming of sudden money windfall? After today report will make many sober and be more realistic on their expectations. Invest based on fundamentals not on rumour. Read the result as published today - https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=7005

Very creditable and strong profit performance for 3 QR. Hopefully,recovery process continue to next quarter(QR) considering the strong steel price in the global market even though recently has somewhat stabilised. Read from : https://www.malaysiastock.biz/Corporate-Infomation.aspx?securityCode=5665

With the latest news no need to involve UCrest. Read : https://www.theedgemarkets.com/article/pharmaniaga-supply-38-million-sinovac-vaccine-doses-endjune-additional-104-million-doses

https://www.theedgemarkets.com/article/pharmaniaga-works-federal-govt-only-covid19-vaccine-now

At times,can see many of the investors take differing or divergent views to theirs in a very bellicose, belligerent and antagonistic manners which should not happen at all since we are all grown ups and each one is free and at liberty to put their opinion on the stock.
A2. No man has a monopoly on the movement - momentum,speed, and trending of the stock performance. The views put forth are for us to see in another perspective contrary to your or me.

No man is an island.

Read on vaccine procurement made by Zaid Ibrahim - https://www.freemalaysiatoday.com/category/opinion/2021/05/22/use-emergency-to-speed-up-vaccine-purchases/

@Loh Kok Wai emphatised with you but the technical readings of the momentum,speed, and trend indicators for the Bursa trading next week is not favourable. Bias is still toward downtrend. Aggravated further by topical factors like increasing Covid-19 cases, volatility in global equities market, and our country's uncertain political landscape.
A2. Coming back to DNex you can go for buy and sell daily trading approach to make some small returns if you are lucky. To decide further you can peruse through the graphs for the counter - https://www.malaysiastock.biz/Stock-Chart.aspx?securitycode=4456&mode=1D
A3. As for me trying to downsize most of my major equities' holdings.More turbulence ahead which were beyond our controls.

Just to share.Good luck.

@yiqqre my response. Lately, Unusual Market Activity (UMA) letters were issued to public listed companies by Bursa when their share prices were unrelentingly pumped up to reach ridiculous highs. These include companies mostly mid-size capitalization, poor performing, and weak fundamentals.
After oft similar replies were made to Bursa, their prices will continue to ascend incredulously next to even more new high. The price moves, actions, and patterns recorded over the trading days were noticeably spurious. Investing public needs strong and effective regulators to ensure the equity market is devoid of any pernicious manipulation to safeguard their better interests.

I am very skeptical of such Sputnik V vaccine deal by the so-called parties as announced.Based on the following reasons, viz:
A1. Many parties or companies have made and signed Memorandum of Understanding (MOU). But how many going by past records have been successful. Out of 1333 MOUs( or what you can called MOC,MOA) only 5 successful; 8 aborted, and the rest in the quagmire(or in short under KIV).
A2. Such similar vaccines' deals also have been signed by many public-listed companies but after several months what good results have they have to show? Or just riding on the hype in lieu of the Covid-19 pandemic spread?
A3. The Russian Direct Investment Fund(RDIF) as named in the MOU when that is out of its founding objective.
Read the extract regarding RFID) here : Russian Direct Investment Fund
The Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 by the Russian government to make investments in leading companies of high-growth sectors of the Russian economy. Its mandate is to co-invest alongside the world’s largest institutional investors — direct investment funds, sovereign wealth funds and leading companies.
RDIF therefore acts as a catalyst for direct investment in Russia.
A4. What make a big national sovereign fund deal with a sub-par performing company for such deal?
A5. Why the contract manufacturers in China was not named? Why not import the Sputnik V vaccine directly from Russia. Would it not be better outmode? Opines,Russia government would not allow for the vaccine to be contract manufactured in China because they are afraid of losing the intellectual protection rights(IPRs) for the vaccine development.
A5. This company stock price is only hovering within a narrow range of 0.15 cents for several years. With about RM 220 million paid up capital they can only showed about RM 30 million revenues for the last three(3) years. EPS,ROE all in the negatives.NTA only 0.08 cents. No dividends for several years.

Determination : At the last week closing price of 0.355 cents is very much overvalued.Not supported by any sound fundamentals and forward earning potential not visible.The MOUs has been all hyped up. With such facts shared with no prejudice would you put your money into such stock??? Think wisely.Be your own man and makes a smart investing choice. Separate hype(fiction) from market fundamentals so as not to lose your money invested into stocks.

Lately, Unusual Market Activity (UMA) letters were issued to public listed companies by Bursa when their share prices were unrelentingly pumped up to reach ridiculous highs. These include companies mostly mid-size capitalization, poor performing, and weak fundamentals.
After oft similar replies were made to Bursa, their prices will continue to ascend incredulously next to even more new high. The price moves, actions, and patterns recorded over the trading days were noticeably spurious. Investing public needs strong and effective regulators to ensure the equity market is devoid of any pernicious manipulation to safeguard their better interests.

Lately, Unusual Market Activity (UMA) letters were issued to public listed companies by Bursa when their share prices were unrelentingly pumped up to reach ridiculous highs. These include companies mostly mid-size capitalization, poor performing, and weak fundamentals.
After oft similar replies were made to Bursa, their prices will continue to ascend incredulously next to even more new high. The price moves, actions, and patterns recorded over the trading days were noticeably spurious. Investing public needs strong and effective regulators to ensure the equity market is devoid of any pernicious manipulation to safeguard their better interests.

Lately, Unusual Market Activity (UMA) letters were issued to public listed companies by Bursa when their share prices were unrelentingly pumped up to reach ridiculous highs. These include companies mostly mid-size capitalization, poor performing, and weak fundamentals.
After oft similar replies were made to Bursa, their prices will continue to ascend incredulously next to even more new high. The price moves, actions, and patterns recorded over the trading days were noticeably spurious. Investing public needs strong and effective regulators to ensure the equity market is devoid of any pernicious manipulation to safeguard their better interests.

Lately, Unusual Market Activity (UMA) letters were issued to public listed companies by Bursa when their share prices were unrelentingly pumped up to reach ridiculous highs. These include companies mostly mid-size capitalization, poor performing, and weak fundamentals.
After oft similar replies were made to Bursa, their prices will continue to ascend incredulously next to even more new high. The price moves, actions, and patterns recorded over the trading days were noticeably spurious. Investing public needs strong and effective regulators to ensure the equity market is devoid of any pernicious manipulation to safeguard their better interests.

As a number of comments made this low performing company's revenue only comes to RM 10million last year and financials very weak. That when the shares issued were at 303.26 million.This is one clear and good example of "pump and dump" stock which will attract & trap many greedy investors in the market when the "party" stops.
A2.ESOS in the millions issued at only ) 0.128 cents.Just do a simple calculation how much they earned easy money without showing credible profit performance and financials.
A3.Who took up the PP must be disclosed for transparency and good corporate governance.
A4.What visible forward earnings that they can show to the investors?
A5. Can deduce the present stock price has been unrelentingly pumped up for no fundamental and good reasons to support the price. Who profit immensely from such high stock price? Your guess is as good as mine. Time for BURSA and Securities Commission (SC) to act and be seen doing their jobs as regulators.

Buy at your own risk. Don't be the last player holding a very much overvalued shares when the party stops.

@mushroom agreed. That if perusing through the Technical Charts as appended here.
> SMA 10,SMA200,MACD,RSI and trading moves not supportive of the stock price.
>the SMA 10 has crossed the SMA200 line on 29 Mar 2021 at 0.57 cents and from there descend and fall to the lowly price recorded yesterday 0.42cents.
>EPS,ROE not attractive, and P/E ratio very high at 280 when the P/E for the market is at about 18-20.

Outcome: so long as the forward earning streams(every quarter) is not visible the present price will move within a narrow range.Show, and share with us the catalysts that can move the price. Otherwise, it is a wasted hope, hoping for the price to increase. Charts : https://www.malaysiastock.biz/Stock-Chart.aspx?securitycode=0162&mode=1D

A1. Ineffectual for the equities or securities regulators to issue standard Unusual Market Activity(UMA) one after another to public -listed companies that have seen their shares' prices spiked,increased, and pumped up by a big, and unusual amount. Such incredulous, and bizarre market moves and trends smacked of market's rigging, cornering, and gross manipulation activities by irresponsible groups to snarl, and entrap the many gullible retail investors in the market place.Cannot discern any fundamental,logical or sound reasons to support the sudden price increase for a great number of listed shares that have negative EPS,ROE,very high PE ratio, forward earning potential not visible, decreasing or stagnant revenues year after year,etc
A2.Afer the UMA letter the said share price irregular moves take place and repeated all over again. What does that tell you as a concerned and value-added investors? Show total disregard to the UMA or whatever supervision and monitoring by the regulators.
A3. That clearly show that the regulators need to act tough,decisive and strong on such irregular market's trading activities which were bordering, and descending on irrational exuberance. And to serve as a stern , and clear warning to other recalcitrant public listed companies in Bursa.
A4. Vitally important that there were array of securities laws to be enforced, and the regulators have to be seen to be doing their jobs,duties, and responsibilities well, and proactive.
A5.That to prevent any big losses to be incurred by the retail investors which have NO control,influence and power over such irregular market's price moves.

The ball is with the regulators NOW to show that they are doing the right things, and doing things right.

No prejudice meant to any party.Just to ensure the equity market function in the proper, progressive and regulated manner.

A1. Ineffectual for the equities or securities regulators to issue standard Unusual Market Activity(UMA) one after another to public -listed companies that have seen their shares' prices spiked,increased, and pumped up by a big, and unusual amount. Such incredulous, and bizarre market moves and trends smacked of market's rigging, cornering, and gross manipulation activities by irresponsible groups to snarl, and entrap the many gullible retail investors in the market place.Cannot discern any fundamental,logical or sound reasons to support the sudden price increase for a great number of listed shares that have negative EPS,ROE,very high PE ratio, forward earning potential not visible, decreasing or stagnant revenues year after year,etc
A2.Afer the UMA letter the said share price irregular moves take place and repeated all over again. What does that tell you as a concerned and value-added investors? Show total disregard to the UMA or whatever supervision and monitoring by the regulators.
A3. That clearly show that the regulators need to act tough,decisive and strong on such irregular market's trading activities which were bordering, and descending on irrational exuberance. And to serve as a stern , and clear warning to other recalcitrant public listed companies in Bursa.
A4. Vitally important that there were array of securities laws to be enforced, and the regulators have to be seen to be doing their jobs,duties, and responsibilities well, and proactive.
A5.That to prevent any big losses to be incurred by the retail investors which have NO control,influence and power over such irregular market's price moves.

The ball is with the regulators NOW to show that they are doing the right things, and doing things right.

No prejudice meant to any party.Just to ensure the equity market function in the proper, progressive and regulated manner.

A1. Ineffectual for the equities or securities regulators to issue standard Unusual Market Activity(UMA) one after another to public -listed companies that have seen their shares' prices spiked,increased, and pumped up by a big, and unusual amount. Such incredulous, and bizarre market moves and trends smacked of market's rigging, cornering, and gross manipulation activities by irresponsible groups to snarl, and entrap the many gullible retail investors in the market place.Cannot discern any fundamental,logical or sound reasons to support the sudden price increase for a great number of listed shares that have negative EPS,ROE,very high PE ratio, forward earning potential not visible, decreasing or stagnant revenues year after year,etc
A2.Afer the UMA letter the said share price irregular moves take place and repeated all over again. What does that tell you as a concerned and value-added investors? Show total disregard to the UMA or whatever supervision and monitoring by the regulators.
A3. That clearly show that the regulators need to act tough,decisive and strong on such irregular market's trading activities which were bordering, and descending on irrational exuberance. And to serve as a stern , and clear warning to other recalcitrant public listed companies in Bursa.
A4. Vitally important that there were array of securities laws to be enforced, and the regulators have to be seen to be doing their jobs,duties, and responsibilities well, and proactive.
A5.That to prevent any big losses to be incurred by the retail investors which have NO control,influence and power over such irregular market's price moves.

The ball is with the regulators NOW to show that they are doing the right things, and doing things right.

No prejudice meant to any party.Just to ensure the equity market function in the proper, progressive and regulated manner.

@calvintaneng thanks for the logical and good advice to many gullible investors in the market. Take care. Stay safe.Stay smart.

Be your own man.And know what you are doing.

Have written to get the notice of the equity market regulator. Widetech is going to be " Wide Trap" as inferred by one stock commentators. To know more -https://www.theedgemarkets.com/article/following-bursa-query-widetech-says-not-aware-reason-behind-unusual-market-activity

Have written to get the notice of the equity market regulator. To know more - https://www.theedgemarkets.com/article/following-bursa-query-widetech-says-not-aware-reason-behind-unusual-market-activity

This stock has to further drop to the range between its historical low at about 0.50 cents. Prospective revenues,forward earning flows,etc poor.

@Riazi954 fully agreed with you.And Serba undertook two PPs between the short span of one year.Such PPs devalued the market value for the holdings of existing minority shareholders.Because the price has to be adjusted down with the increase in number of new issued shares.
A2.Who took up the PPs should have been disclosed for transparency and good corporate governance? Who are the parties?
A3. If the company is serious of the greater interests of the minority shareholders they can consider other ways to raise the necessary capital if warranted.And reward the minority.
A4.One can notice once a PP is announced the market will rebel and ensure the price is driven down or falls.
A5.Two times caught in such imbroglios and now totally avoid this stock.

Just to share with no prejudice.